NEUROCONTROL'S FREEHAND NEUROPROSTHESIS NEEDS MORE EMC DATA, FDA PANEL SAYS IN UNANIMOUS VOTE TO RECOMMEND PMA APPROVAL WITH CONDITIONS
This article was originally published in The Gray Sheet
Executive Summary
NeuroControl's Freehand neuroprosthesis needs additional data on electromagnetic compatibility to establish the safety of the device, FDA's Neurological Devices Panel concluded at a Sept. 25 meeting in Rockville, Maryland.